{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:02:42Z","timestamp":1787065362242,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>Capecitabine is a commonly used oral chemotherapeutic agent. Gastrointestinal (GI) side effects are clinically well-known, however, the histopathologic changes have not been comprehensively studied. This study describes the largest case series (8 patients) characterizing the histopathology of capecitabine-induced GI injury. All patients were adults (median age: 64.5\u00a0y, range: 61 to 76\u00a0y) and there was gender parity. Patients were receiving treatment for malignancies of the colorectum (n=5), breast (n=1), pancreas (n=1), and appendix (n=1). All had GI symptoms, including 7 with diarrhea and abdominal pain and 1 with melena. Five of 8 (63%) showed graft-versus-host disease (GVHD)-like histologic changes in small intestinal and\/or colonic biopsies characterized by crypt disarray and dropout, crypt atrophy, dilated crypts lined by attenuated epithelium, and increased crypt apoptosis. Neuroendocrine cell aggregates were present in 4 of 5 cases. Four of 5 showed patchy prominence in lamina propria eosinophils. One patient receiving concomitant radiation therapy had a small intestinal biopsy showing regenerative changes. Two patients had histologically unremarkable biopsies. On follow-up, capecitabine was discontinued or dose-reduced in all patients. Three of 5 patients with a GVHD-like pattern had clinical improvement, whereas 2 died shortly after biopsy. One with regenerative changes also had radiation dose reduction and improved clinically. Two with unremarkable biopsies improved symptomatically. In summary, capecitabine-related GI injury shows a GVHD-like pattern. Knowledge of this is important to confirm the diagnosis as patients typically improve with dose reduction or discontinuation of the drug.<\/jats:p>","DOI":"10.1097\/pas.0000000000002093","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T07:00:12Z","timestamp":1690354812000},"page":"1160-1167","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Capecitabine-induced Gastrointestinal Injury Shows a Graft-Versus-Host Disease (GVHD)-like Pattern"],"prefix":"10.1097","volume":"47","author":[{"given":"Kenechukwu","family":"Ojukwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent K.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Guindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle A.","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clinthera.2005.01.005","article-title":"Capecitabine: a review","volume":"27","author":"Walko","year":"2005","journal-title":"Clin Ther"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.3390\/molecules13081897","article-title":"Efficacy of the oral fluorouracil pro-drug capecitabine in cancer treatment: a review","volume":"13","author":"Koukourakis","year":"2008","journal-title":"Molecules"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jclinpath-2014-202199","article-title":"Apoptotic enteropathy caused by antimetabolites and TNF-\u03b1 antagonists","volume":"67","author":"Soldini","year":"2014","journal-title":"J Clin Pathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1746-1596-8-150","article-title":"Lethal cardiotoxicity, steatohepatitis, chronic pancreatitis, and acute enteritis induced by capecitabine and oxaliplatin in a 36-year-old woman","volume":"8","author":"Gurzu","year":"2013","journal-title":"Diagn Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1053\/j.gastro.2018.11.076","article-title":"Capecitabine-induced enteritis leading to small bowel obstruction","volume":"156","author":"Pow-Anpongkul","year":"2019","journal-title":"Gastroenterology"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/1120009X.2021.2025316","article-title":"Capecitabine-associated enterocolitis: narrative literature review of a rare adverse event and a case presentation","volume":"35","author":"Trontzas","year":"2023","journal-title":"J Chemother"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"e231544","DOI":"10.1136\/bcr-2019-231544","article-title":"Treatment-resistant severe capecitabine-induced diarrhoea resolved with oral budesonide","volume":"12","author":"Shumar","year":"2019","journal-title":"BMJ Case Rep"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5005\/jp-journals-10018-1148","article-title":"A case report of ulcerative colitis induced by therapy of colorectal carcinoma","volume":"5","author":"Temel","year":"2015","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1159\/000492781","article-title":"Capecitabine-associated terminal ileitis","volume":"11","author":"van Hellemond","year":"2018","journal-title":"Case Rep Oncol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"bcr2014203647","DOI":"10.1136\/bcr-2014-203647","article-title":"Breast cancer, DPYD mutations and capecitabine-related ileitis: description of two cases and a review of the literature","volume":"2014","author":"Mokrim","year":"2014","journal-title":"BMJ Case Rep"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4253\/wjge.v11.i5.383","article-title":"Role of colonoscopy in diagnosis of capecitabine associated ileitis: two case reports","volume":"11","author":"Dao","year":"2019","journal-title":"World J Gastrointest Endosc"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12957-021-02443-8","article-title":"Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature","volume":"19","author":"Zou","year":"2021","journal-title":"World J Surg Oncol"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"661","DOI":"10.5144\/0256-4947.2012.661","article-title":"Capecitabine-induced terminal ileitis","volume":"32","author":"Al-Gahmi","year":"2012","journal-title":"Ann Saudi Med"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.prp.2014.05.005","article-title":"Capecitabine induced colitis","volume":"210","author":"Maggo","year":"2014","journal-title":"Pathol Res Pract"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12029-010-9243-z","article-title":"Capecitabine-induced, nonneutropenic enterocolitis","volume":"42","author":"Gordon","year":"2011","journal-title":"J Gastrointest Cancer"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/PAS.0b013e31829ab1ef","article-title":"Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis","volume":"37","author":"Star","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14740\/wjon1186","article-title":"A case of pneumatosis intestinalis with pneumoperitoneum as a potential delayed adverse effect of capecitabine","volume":"10","author":"Khan","year":"2019","journal-title":"World J Oncol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3892\/mco.2015.635","article-title":"Severe ileitis associated with capecitabine: two case reports and review of the literature","volume":"3","author":"Lee","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/annonc\/mdn397","article-title":"Large bowel perforation associated with capecitabine treatment for breast cancer","volume":"19","author":"Cowman","year":"2008","journal-title":"Ann Oncol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/OP.20.00553","article-title":"All you need to know about DPYD genetic testing for patients treated with fluorouracil and capecitabine: a practitioner-friendly guide","volume":"16","author":"Innocenti","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF03256229","article-title":"Rapid detection of the DPYD IVS14+1G>A mutation for screening patients to prevent fluorouracil-related toxicity","volume":"11","author":"Bosch","year":"2007","journal-title":"Mol Diagn Ther"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00280-020-04093-1","article-title":"New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine","volume":"86","author":"Garc\u00eda-Gonz\u00e1lez","year":"2020","journal-title":"Cancer Chemother Pharmacol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/jcp.46.2.118","article-title":"Importance of apoptosis in the histopathology of drug related lesions in the large intestine","volume":"46","author":"Lee","year":"1993","journal-title":"J Clin Pathol"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/ajcp\/110.5.622","article-title":"The histopathology of nonsteroidal anti-inflammatory drug-associated colitis","volume":"110","author":"Goldstein","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"397","DOI":"10.12659\/AOT.893616","article-title":"Graft-versus-host disease after liver transplantation: a single-center case series","volume":"20","author":"Elsiesy","year":"2015","journal-title":"Ann Transplant"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.5858\/arpa.2015-0204-RA","article-title":"Olmesartan-associated enteropathy: a review of clinical and histologic findings","volume":"139","author":"Choi","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/gastro\/goz019","article-title":"Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review","volume":"7","author":"Kamal","year":"2019","journal-title":"Gastroenterol Rep"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T16:03:28Z","timestamp":1749398608000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002093","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,27]]}}}